Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart

Muhammad Idris Niagara, Husnain Kh Haider, Shujia Jiang, Muhammad Ashraf

Research output: Contribution to journalArticle

151 Citations (Scopus)

Abstract

Strategies to enhance skeletal myoblast (SkM) survival after transplantation in the ischemic heart have achieved little success. We posit that preconditioned (PC) SkMs show improved survival and promote repair of the infarcted myocardium via paracrine signaling after transplantation. SkMs from male Fischer-344 rats (rSkMs) were PC for 30 minutes with 200 μmol/L diazoxide. Treatment of PC rSkMs with 100 μmol/L H2O2 for 2 hours resulted in significantly reduced cell injury, as shown by lactate dehydrogenase-release assay, and prevented apoptosis, as demonstrated by cytochrome c translocation, TUNEL, annexin V staining, and preservation of mitochondrial membrane potential. PC rSkMs expressed elevated phospho-Akt (1.85-fold), basic fibroblast growth factor (1.44-fold), hepatocyte growth factor (2.26-fold), and cyclooxygenase-2 (1.33-fold) as compared with non-PC rSkMs. For in vivo studies, female Fischer-344 rats after permanent coronary artery ligation were grouped (n=12/group) to receive 80 μL of basal medium without rSkMs (group 1) or containing 1.5×10 non-PC (group 2) or PC (group 3) rSkMs. Real-time PCR for sry gene 4 days after transplantation (n=4/group) showed 1.93-fold higher survival of rSkMs in group 3 as compared with group 2. Four weeks later, echocardiography revealed improved indices of left ventricular function, including ejection fraction and fractional shortening in group 3 (P<0.02) as compared with groups 1 and 2. Blood vessel count per surface area (at ×400 magnification) was highest in scar and periscar areas in group 3 as compared with the other groups (P<0.05). We conclude that activation of signaling pathways of preconditioning in SkMs promoted their survival by release of paracrine factors to promote angiomyogenesis in the infarcted heart. Transplantation of PC SkMs for heart cell therapy is an innovative approach in the clinical perspective.

Original languageEnglish (US)
Pages (from-to)545-555
Number of pages11
JournalCirculation research
Volume100
Issue number4
DOIs
StatePublished - Mar 1 2007
Externally publishedYes

Fingerprint

Skeletal Myoblasts
Oxidative Stress
Transplantation
Inbred F344 Rats
sry Genes
Paracrine Communication
Diazoxide
Hepatocyte Growth Factor
Mitochondrial Membrane Potential
Annexin A5
In Situ Nick-End Labeling
Fibroblast Growth Factor 2
Cyclooxygenase 2
Cell- and Tissue-Based Therapy
Cytochromes c
Left Ventricular Function
L-Lactate Dehydrogenase
Cicatrix
Ligation
Blood Vessels

Keywords

  • Angiogenesis
  • Apoptosis
  • Myocardial infarction
  • Preconditioning

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. / Niagara, Muhammad Idris; Haider, Husnain Kh; Jiang, Shujia; Ashraf, Muhammad.

In: Circulation research, Vol. 100, No. 4, 01.03.2007, p. 545-555.

Research output: Contribution to journalArticle

@article{e4760e60db7b41f69e0a660b5e7c5773,
title = "Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart",
abstract = "Strategies to enhance skeletal myoblast (SkM) survival after transplantation in the ischemic heart have achieved little success. We posit that preconditioned (PC) SkMs show improved survival and promote repair of the infarcted myocardium via paracrine signaling after transplantation. SkMs from male Fischer-344 rats (rSkMs) were PC for 30 minutes with 200 μmol/L diazoxide. Treatment of PC rSkMs with 100 μmol/L H2O2 for 2 hours resulted in significantly reduced cell injury, as shown by lactate dehydrogenase-release assay, and prevented apoptosis, as demonstrated by cytochrome c translocation, TUNEL, annexin V staining, and preservation of mitochondrial membrane potential. PC rSkMs expressed elevated phospho-Akt (1.85-fold), basic fibroblast growth factor (1.44-fold), hepatocyte growth factor (2.26-fold), and cyclooxygenase-2 (1.33-fold) as compared with non-PC rSkMs. For in vivo studies, female Fischer-344 rats after permanent coronary artery ligation were grouped (n=12/group) to receive 80 μL of basal medium without rSkMs (group 1) or containing 1.5×10 non-PC (group 2) or PC (group 3) rSkMs. Real-time PCR for sry gene 4 days after transplantation (n=4/group) showed 1.93-fold higher survival of rSkMs in group 3 as compared with group 2. Four weeks later, echocardiography revealed improved indices of left ventricular function, including ejection fraction and fractional shortening in group 3 (P<0.02) as compared with groups 1 and 2. Blood vessel count per surface area (at ×400 magnification) was highest in scar and periscar areas in group 3 as compared with the other groups (P<0.05). We conclude that activation of signaling pathways of preconditioning in SkMs promoted their survival by release of paracrine factors to promote angiomyogenesis in the infarcted heart. Transplantation of PC SkMs for heart cell therapy is an innovative approach in the clinical perspective.",
keywords = "Angiogenesis, Apoptosis, Myocardial infarction, Preconditioning",
author = "Niagara, {Muhammad Idris} and Haider, {Husnain Kh} and Shujia Jiang and Muhammad Ashraf",
year = "2007",
month = "3",
day = "1",
doi = "10.1161/01.RES.0000258460.41160.ef",
language = "English (US)",
volume = "100",
pages = "545--555",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart

AU - Niagara, Muhammad Idris

AU - Haider, Husnain Kh

AU - Jiang, Shujia

AU - Ashraf, Muhammad

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Strategies to enhance skeletal myoblast (SkM) survival after transplantation in the ischemic heart have achieved little success. We posit that preconditioned (PC) SkMs show improved survival and promote repair of the infarcted myocardium via paracrine signaling after transplantation. SkMs from male Fischer-344 rats (rSkMs) were PC for 30 minutes with 200 μmol/L diazoxide. Treatment of PC rSkMs with 100 μmol/L H2O2 for 2 hours resulted in significantly reduced cell injury, as shown by lactate dehydrogenase-release assay, and prevented apoptosis, as demonstrated by cytochrome c translocation, TUNEL, annexin V staining, and preservation of mitochondrial membrane potential. PC rSkMs expressed elevated phospho-Akt (1.85-fold), basic fibroblast growth factor (1.44-fold), hepatocyte growth factor (2.26-fold), and cyclooxygenase-2 (1.33-fold) as compared with non-PC rSkMs. For in vivo studies, female Fischer-344 rats after permanent coronary artery ligation were grouped (n=12/group) to receive 80 μL of basal medium without rSkMs (group 1) or containing 1.5×10 non-PC (group 2) or PC (group 3) rSkMs. Real-time PCR for sry gene 4 days after transplantation (n=4/group) showed 1.93-fold higher survival of rSkMs in group 3 as compared with group 2. Four weeks later, echocardiography revealed improved indices of left ventricular function, including ejection fraction and fractional shortening in group 3 (P<0.02) as compared with groups 1 and 2. Blood vessel count per surface area (at ×400 magnification) was highest in scar and periscar areas in group 3 as compared with the other groups (P<0.05). We conclude that activation of signaling pathways of preconditioning in SkMs promoted their survival by release of paracrine factors to promote angiomyogenesis in the infarcted heart. Transplantation of PC SkMs for heart cell therapy is an innovative approach in the clinical perspective.

AB - Strategies to enhance skeletal myoblast (SkM) survival after transplantation in the ischemic heart have achieved little success. We posit that preconditioned (PC) SkMs show improved survival and promote repair of the infarcted myocardium via paracrine signaling after transplantation. SkMs from male Fischer-344 rats (rSkMs) were PC for 30 minutes with 200 μmol/L diazoxide. Treatment of PC rSkMs with 100 μmol/L H2O2 for 2 hours resulted in significantly reduced cell injury, as shown by lactate dehydrogenase-release assay, and prevented apoptosis, as demonstrated by cytochrome c translocation, TUNEL, annexin V staining, and preservation of mitochondrial membrane potential. PC rSkMs expressed elevated phospho-Akt (1.85-fold), basic fibroblast growth factor (1.44-fold), hepatocyte growth factor (2.26-fold), and cyclooxygenase-2 (1.33-fold) as compared with non-PC rSkMs. For in vivo studies, female Fischer-344 rats after permanent coronary artery ligation were grouped (n=12/group) to receive 80 μL of basal medium without rSkMs (group 1) or containing 1.5×10 non-PC (group 2) or PC (group 3) rSkMs. Real-time PCR for sry gene 4 days after transplantation (n=4/group) showed 1.93-fold higher survival of rSkMs in group 3 as compared with group 2. Four weeks later, echocardiography revealed improved indices of left ventricular function, including ejection fraction and fractional shortening in group 3 (P<0.02) as compared with groups 1 and 2. Blood vessel count per surface area (at ×400 magnification) was highest in scar and periscar areas in group 3 as compared with the other groups (P<0.05). We conclude that activation of signaling pathways of preconditioning in SkMs promoted their survival by release of paracrine factors to promote angiomyogenesis in the infarcted heart. Transplantation of PC SkMs for heart cell therapy is an innovative approach in the clinical perspective.

KW - Angiogenesis

KW - Apoptosis

KW - Myocardial infarction

KW - Preconditioning

UR - http://www.scopus.com/inward/record.url?scp=33947546577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947546577&partnerID=8YFLogxK

U2 - 10.1161/01.RES.0000258460.41160.ef

DO - 10.1161/01.RES.0000258460.41160.ef

M3 - Article

C2 - 17234963

AN - SCOPUS:33947546577

VL - 100

SP - 545

EP - 555

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 4

ER -